Novartis’ (NVS) eye care spinoff Alcon is ready to go. The distribution is set for April 9th and both shareholders and ADR holders as of April 8th will receive one share of Alcon stock for every 5 Novartis shares owned. Alcon will trade in both Switzerland and the NYSE under the ticker ‘ALC’ so a shareholder with 100… Read More »
Lets close the week with some Odds & Ends. In this week’s edition, we provide some updates on recent and upcoming spinoffs. We also give thanks to a reader for pointing out something we missed – keep it up! Thanks to reader AH for pointing out that we missed Naspers (NPSNY) spinoff of its Pay-TV business, MultiChoice Group… Read More »
The vision of an independent Alcon is getting closer to reality. As part of its year end earnings release, Novartis (NVS) revealed many more details about the upcoming eye care spinoff which is expected to be completed in the first half of this year. It seems the target is actually sometime in April, but first shareholders will have their… Read More »
Earlier this year Novartis (NVS) CEO Joe Jimenez said the company was considering a sale or a spinoff of Alcon, its surgical equipment and eye care business. The company paid a hefty penny (actually ~$50b worth of pennies) to acquire the business back in 2010, but as with a lot of M&A, things haven’t gone as planned. Many… Read More »